EichorEICHOR
Study identifier: NCT05686317 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Active Not Recruiting

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

Condition: Heart Failure  ·  Sponsor: Edwards Lifesciences

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, multi-center, randomized, sham-controlled, double-blinded (participant and outcomes assessor) clinical trial.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (25)

University of California IrvineIrvine, California, United States
University of California San DiegoLa Jolla, California, United States
Scripps HealthLa Jolla, California, United States
University of Southern CaliforniaLos Angeles, California, United States
University of California San FranciscoSan Francisco, California, United States
Ascension Illinois Heart and Vascular Medical GroupElk Grove, Illinois, United States
Kansas University Medical CenterKansas City, Kansas, United States
Abbott Northwestern HospitalMinneapolis, Minnesota, United States
Mayo ClinicRochester, Minnesota, United States
St. Francis Hospital & Heart CenterRoslyn, New York, United States
Montefiore Medical CenterThe Bronx, New York, United States
The Christ HospitalCincinnati, Ohio, United States

+ 13 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →